Faruqi & Faruqi, LLP is Investigating CareFusion Corporation on Behalf of its Shareholders - CFN
Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and the enforcement of federal antitrust laws, is investigating potential claims against the Board of Directors of CareFusion Corporation (“CareFusion” or the “Company”) (NYSE: CFN) concerning possible breaches of fiduciary duty and other violations of law.
The investigation concerns actions by CareFusion’s Board of Directors that have caused the Company to allegedly violate the False Claims Act by paying kickbacks to medical professionals and promoting its ChloraPrep products for uses that were not approved by the Food and Drug Administration (FDA). CareFusion has agreed to pay the government $40.1 million to settle these allegations. Shareholders interested in seeking to recover damages on behalf of CareFusion and to implement corporate governance measures designed to prevent future misconduct should contact the firm.
If you hold CFN shares and you would like to discuss your legal rights, please contact Michael J. Hynes for free at 877-247-4292 or at 215-277-5770 or send an e-mail to email@example.com.